C
Coeptis Therapeutics Inc
NASDAQ:COEP
Coeptis Therapeutics Inc
NASDAQ:COEP
Price:
11.45
USD
-1.04%
Market Closed
Market Cap:
$66m
Cash Flow Statement
Cash Flow Statement
Coeptis Therapeutics Inc
Coeptis Therapeutics Inc
Currency: USD
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(33)
|
(38)
|
(29)
|
(38)
|
(55)
|
(49)
|
(57)
|
(21)
|
|
| Depreciation & Amortization |
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
28
|
33
|
25
|
33
|
47
|
40
|
48
|
11
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(2)
|
(2)
|
0
|
(1)
|
(0)
|
(0)
|
(1)
|
2
|
|
| Cash from Operating Activities |
(5)
N/A
|
(6)
-7%
|
(3)
+53%
|
(4)
-40%
|
(7)
-70%
|
(7)
-13%
|
(9)
-19%
|
(7)
+18%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
43
|
0
|
0
|
(0)
|
(43)
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
(1)
N/A
|
46
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(43)
-12 098%
|
0
N/A
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
11
|
8
|
0
|
9
|
1
|
3
|
4
|
5
|
|
| Net Issuance of Debt |
(2)
|
(1)
|
(5)
|
(2)
|
(2)
|
(2)
|
(3)
|
(1)
|
|
| Other |
(0)
|
0
|
(42)
|
(1)
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
9
N/A
|
7
-22%
|
(44)
N/A
|
5
N/A
|
7
+19%
|
9
+35%
|
51
+476%
|
5
-90%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
2
N/A
|
0
-78%
|
(1)
N/A
|
2
N/A
|
(0)
N/A
|
1
N/A
|
(0)
N/A
|
(2)
-515%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(5)
N/A
|
(7)
-26%
|
(3)
+60%
|
(4)
-40%
|
(7)
-70%
|
(7)
-13%
|
(9)
-19%
|
(7)
+18%
|
|
Switch to:
Switch to:
See Also
Discover More
